Purchase Order 75N91025P00088
Award Date
11/27/24
Potential Completion Date
11/26/28
Potential Value
$804K
Federal Agency
National Cancer Institute
Awardee
Vector Biomed Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
North Potomac, MD 20878, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) awarded a purchase order contract valued at one hundred twenty thousand six hundred dollars ($120,600) to Vector Biomed Inc. The contract is to obtain preclinical grade lentiviral vectors in support of NCI's Pediatric Oncology Branch investigational new drug enabling studies and demonstration of clinical-grade vector production feasibility. Services include receipt confirmation...
This firm-fixed price purchase order contract was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Expression Manufacturing LLC, a for-profit limited liability company, to provide 250 ml of concentrated lentiviral vector and conduct stability testing. The contract, valued at $648,968.00, has an ultimate completion date of August 31, 2029. This sole-source procurement was originally...
This firm-fixed-price purchase order contract was awarded by the National Center for Advancing Translational Sciences (NCATS), part of the U.S. Department of Health and Human Services, to Vector Biosystems, Inc. (doing business as Vector Biolabs), a for-profit biotechnology company that provides gene delivery products and services. The $16,120 contract is for the delivery of an AAV viral vector with an EF1a promotor expressing a green fluorescent protein. This contract supports NCATS' biomedical...
This federal contract award, valued at $10,600.00, was issued by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services. The contract was awarded to Vector Biosystems, Inc., doing business as Vector Biolabs, a minority-owned, small disadvantaged biotechnology company that provides gene delivery products and services. The contract is for the delivery of an AAV8-SPC512-MCHERRY construct, which is likely a gene...
The National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the Department of Health and Human Services, awarded a $16,999 firm fixed-price purchase order to Vectorbuilder Inc., a specialized biotechnology company, for large-scale 15 and ultra-purification packaging service for PAAV240227-1016XNQ. The contract, which does not utilize any set-aside designations, has a completion date of September 3, 2025. Vectorbuilder, a global leader in gene delivery...
This is a firm fixed price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Lentigen Technology, Inc. for the manufacture of a good manufacturing practice (GMP) lot of a lentiviral vector encoding a CD19/CD22 targeting bispecific chimeric antigen receptor (CD19/CD22 BiCAR) gene for clinical use. The contract has a ceiling value of $322,000.00 and a completion date of August 7, 2017. The contract was awarded on August 8, 2016 and was not set aside...
This purchase order awards Vector Biosystems, Inc., doing business as Vector Biolabs, $12,060 to deliver two custom adeno-associated viral constructs to the National Center for Advancing Translational Sciences within the Department of Health and Human Services' National Institutes of Health. Specifically, Vector Biosystems will provide one AAV6 vector containing GFP and an shRNA targeting human COLQ, and one AAV6 vector containing GFP and an shRNA targeting human DOK7. Both constructs are to...
The National Institute of Neurological Disorders and Stroke, a component of the National Institutes of Health, awarded a $15,238 firm fixed price purchase order to Vectorbuilder Inc. for AAV8 large-scale 10 and ultra-purification packaging services. The contract has an ultimate completion date of August 26, 2025. Vectorbuilder is a specialized biotechnology company that provides gene delivery and molecular biology services to various federal agencies, including the Department of Veterans Affairs...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, awarded a $18,728 firm fixed price purchase order to Vectorbuilder Inc. for the generation of an OCVAR8 stable cell line plasmid synthesis services. This contract does not have a set-aside designation, indicating that Vectorbuilder competed for the award in full and open competition. Vectorbuilder is a specialized biotechnology company that provides molecular...
This is a $1,199,956.00 cost-plus-fixed-fee contract awarded by the National Cancer Institute (NCI), a civilian agency, to Nanovector Incorporated. The contract is for "OTHER FUNCTIONS TOPIC 267, MULTIFUNCTIONAL THERAPEUTICS USING ENGINEERED PLANT VIRUS NANOPARTICLES" and was set aside for small businesses. The contract has an ultimate completion date of September 27, 2014 and was awarded on September 28, 2012. This contract appears to be part of the NCI's research and development...